Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survival. (Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2003)

(untitled) - Croucher, P; De Hendrik, R; Perry, M; Hijzen, A; Shipman, C; Lippitt, J; Green, J; Van Marck, E; Van Camp, B; Vanderkerken, K